サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1426483

急性細菌性皮膚・皮膚構造感染症の世界市場レポート 2024

Acute Bacterial Skin And Skin Structure Infections Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
急性細菌性皮膚・皮膚構造感染症の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

急性細菌性皮膚・皮膚構造感染症の市場規模は、今後数年間で大幅な成長が見込まれています。2028年には9.9%の年間複合成長率（CAGR）で171億7,000万米ドルに成長すると予想されます。予測期間中に予測される増加は、世界の疫学要因、市場への新しい治療法のイントロダクション、迅速な診断ツールの開発、患者中心のアプローチ、治療ガイドラインの変更によるものと考えられます。予測期間中に予想される顕著な動向には、患者集団の人口構成、抗生物質耐性に関する懸念、治療アプローチの進歩、メチシリン耐性黄色ブドウ球菌（MRSA）の蔓延、外来治療の重視などが含まれます。

予想される皮膚感染症の有病率の急増により、将来、急性細菌性皮膚・皮膚構造感染症市場の成長が促進されると予想されます。皮膚感染症は、細菌、真菌、ウイルスなどの微生物が皮膚に侵入・増殖し、さまざまな症状や不快感を引き起こします。皮膚感染症の発生率の増加により、急性細菌感染症や皮膚構造感染症に対処するための治療法、抗生物質、革新的な治療法に対する需要が高まり、患者が最適なケアと結果を確実に受けられるようにしています。たとえば、英国保健安全庁（UKHSA）は2022年9月、皮膚と軟組織感染症を原因とするメチシリン耐性黄色ブドウ球菌（MRSA）症例の割合が2022年には前年比33.7％に上昇したと報告しました。さらに、MRSA症例は2020年4月から2021年3月までの会計年度に25.7%増加しました。その結果、皮膚感染症の蔓延が急性細菌性皮膚・皮膚構造感染症市場の成長を促進すると予想されます。

慢性疾患の有病率の増加も、今後数年間で急性細菌性皮膚・皮膚構造感染症市場の成長を促進すると予想されます。慢性疾患は、ゆっくりと進行し、長時間にわたって持続する長期にわたる病状を特徴とし、多くの場合、数年または生涯にわたって続きます。慢性疾患の増加は、細菌性皮膚感染症のリスクを高め、治療、入院、専門的なケア、調査、国民の意識、ヘルスケア費の増加、罹患者に合わせた介入の増加を必要とすることで、急性細菌性皮膚・皮膚構造感染症市場に貢献します。その実例として、世界保健機関は2022年9月、世界の年間死亡者数4,100万人のうち74％が非感染性疾患（NCD）または慢性疾患によって引き起こされていると報告しました。死亡者数には、心血管疾患による1,790万人、がんによる930万人、慢性呼吸器疾患による410万人、糖尿病による200万人が含まれています。したがって、慢性疾患の有病率の増加は、急性細菌性皮膚・皮膚構造感染症市場の成長の促進力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の急性細菌性皮膚・皮膚構造感染症市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の急性細菌性皮膚・皮膚構造感染症の市場規模実績と成長、2018年～2023年
  • 世界の急性細菌性皮膚・皮膚構造感染症の市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の急性細菌性皮膚・皮膚構造感染症市場、感染症の種類別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 院内感染による急性細菌性皮膚・皮膚構造感染症
  • 市中感染による急性細菌性皮膚・皮膚構造感染症
  • 世界の急性細菌性皮膚・皮膚構造感染症市場、有効成分別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • デラフロキサシン
  • バンコマイシン
  • セフタロリンフォサミル
  • オリタバンシン
  • テジゾリド
  • ダプトマイシン
  • チゲサイクリン
  • リネゾリド
  • その他の有効成分
  • 世界の急性細菌性皮膚・皮膚構造感染症市場、投与経路別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 経口
  • 非経口
  • 局所
  • 世界の急性細菌性皮膚・皮膚構造感染症市場、流通チャネル別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • 世界の急性細菌性皮膚・皮膚構造感染症市場、用途別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 蜂窩織炎
  • 膿瘍
  • 手術の傷
  • 外傷性の傷

第7章 地域と国の分析

  • 世界の急性細菌性皮膚・皮膚構造感染症市場、地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 世界の急性細菌性皮膚・皮膚構造感染症市場、国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 急性細菌性皮膚・皮膚構造感染症市場の競合情勢
  • 急性細菌性皮膚・皮膚構造感染症市場の企業プロファイル
    • Pfizer Inc.
    • AbbVie Inc.
    • Novartis AG
    • Abbott Laboratories
    • Fresenius SE &Co. KGaA

第31章 その他の大手と革新的な企業

  • GSK PLC
  • Takeda Pharmaceutical Company Limited
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Limited
  • Menarini Group
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Limited
  • Aspen Pharmacare Holdings Limited
  • Lupin Limited
  • Zydus Lifesciences Limited
  • Eurofarma Laboratorios SA
  • Glenmark Pharmaceuticals Ltd.
  • Jiangsu Hansoh Pharmaceutical Group Co. Ltd.
  • Alkem Laboratories Limited

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13495

Acute bacterial skin and skin structure infections (ABSSSIs) represent a category of skin infections caused by bacteria impacting both the skin and underlying tissues, resulting in symptoms such as redness, swelling, pain, and increased warmth in the affected region. Medical interventions, including antibiotic treatments, are employed to prevent complications and facilitate recovery in cases ranging from mild to severe infections.

The primary classifications of acute bacterial skin and skin structure infections encompass hospital-acquired ABSSSIs and community-acquired ABSSSIs. Hospital-acquired ABSSSIs manifest as infections of the skin and underlying tissues that develop due to medical care or hospital stays. Active ingredients in treatments include delafloxacin, vancomycin, ceftaroline fosamil, oritavancin, tedizolid, daptomycin, tigecycline, linezolid, and others, with administration options including oral, parenteral, and topical routes. These treatments are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies, addressing various applications such as cellulitis, abscesses, surgical wounds, and traumatic wounds.

The acute bacterial skin and skin structure infections market research report is one of a series of new reports from The Business Research Company that provides acute bacterial skin and skin structure infections market statistics, including acute bacterial skin and skin structure infections industry global market size, regional shares, competitors with a acute bacterial skin and skin structure infections market share, detailed acute bacterial skin and skin structure infections market segments, market trends and opportunities, and any further data you may need to thrive in the acute bacterial skin and skin structure infections industry. This acute bacterial skin and skin structure infections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acute bacterial skin and skin structure infections market size has grown rapidly in recent years. It will grow from $10.57 billion in 2023 to $11.75 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth observed in the historical period can be credited to innovation in the healthcare industry, economic influences, trends in patient populations, advancements in diagnostic methods, and innovation in clinical trials.

The acute bacterial skin and skin structure infections market size is expected to see strong growth in the next few years. It will grow to $17.17 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%. The increase projected during the forecast period can be ascribed to global epidemiological factors, the introduction of new therapies into the market, swift diagnostic tool development, a patient-centric approach, and changes in treatment guidelines. Prominent trends anticipated in the forecast period involve the demographic composition of the patient population, concerns about antibiotic resistance, progress in treatment approaches, the prevalence of methicillin-resistant Staphylococcus aureus (MRSA), and an emphasis on outpatient treatment.

The anticipated surge in the prevalence of skin infections is poised to drive the growth of the market for acute bacterial skin and skin structure infections in the future. Skin infections involve the invasion and proliferation of microorganisms such as bacteria, fungi, or viruses within the skin, resulting in various symptoms and discomfort. The increasing incidence of skin infections creates a heightened demand for therapeutic solutions, antibiotics, and innovative treatments to address acute bacterial and skin structure infections, ensuring that patients have access to optimal care and outcomes. For example, the UK Health Security Agency (UKHSA) reported in September 2022 that the percentage of Methicillin-resistant Staphylococcus aureus (MRSA) cases caused by skin and soft tissue infections had risen to 33.7% in 2022 from the previous year. Additionally, MRSA cases increased by 25.7% in the financial year spanning April 2020 to March 2021. Consequently, the escalating prevalence of skin infections is expected to propel the growth of the acute bacterial skin and skin structure infections market.

The increasing prevalence of chronic diseases is also anticipated to boost the growth of the acute bacterial skin and skin structure infections market in the coming years. Chronic diseases are characterized by long-term medical conditions that progress slowly and persist over an extended period, often lasting for years or a lifetime. The growth of chronic diseases contributes to the acute bacterial skin and skin structure infections market by heightening the risk of bacterial skin infections, necessitating increased treatments, hospitalizations, specialized care, research, public awareness, healthcare spending, and tailored interventions for affected individuals. As an illustration, the World Health Organization reported in September 2022 that 74% of the 41 million global deaths caused by non-communicable diseases (NCDs) or chronic diseases annually. The deaths included 17.9 million from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Hence, the increasing prevalence of chronic diseases is a driving force behind the growth of the acute bacterial skin and skin structure infections market.

The high cost of treatment is anticipated to impede the market's growth in the future. The term "high cost of treatment" refers to significant financial expenses associated with medical care, procedures, therapies, or interventions. Acute Bacterial Skin and Skin Structure Infections (ABSSSI) can be significantly affected by the high cost of treatment, impacting both individual patients and the healthcare system as a whole. For instance, the Centers for Disease Control and Prevention reported in August 2023 that 6.1% of adults aged 18 and over failed to obtain needed medical care due to cost in 2022. Therefore, the high cost of treatment poses a hindrance to the growth of the acute bacterial skin and skin structure infections market.

Major companies operating in the acute bacterial skin and skin structure infections market are strategically focusing on developing innovative single-dose therapies, such as Dalbonova, to gain a competitive edge. Dalbonova is a single-dose therapy designed for convenience and effectiveness, allowing patients to achieve desired results with a potent 1500 mg dose administered once. For example, in August 2023, BDR Pharmaceuticals Internationals Pvt. Ltd., an India-based pharmaceutical company, launched Dalbonova injection, a single-dose therapy for acute bacterial skin and skin structure infections (ABSSSI). This injection reduces the risk of hospital-acquired diseases by offering a single-dose treatment and eliminating the need for hospital admissions. It is designed to treat ABSSSI caused by certain gram-positive microorganisms in patients of all ages, including newborns.

In April 2021, Endo International PLC, an Ireland-based generics and branded pharmaceutical company, entered into a partnership with Advanz Pharma Corp. Under this collaboration, Endo Ventures Limited is responsible for distribution, sales, marketing, medical affairs, and pricing, while Advanz Pharma is responsible for supplying Xydalba. Xydalba is indicated for treating acute bacterial skin and skin structure infections (ABSSSI) in adults and pediatric patients aged three months and older. Advanz Pharma Corp., a UK-based pharmaceutical company, provides treatment for acute bacterial skin and skin structure infections.

Major companies operating in the acute bacterial skin and skin structure infections market report are Pfizer Inc., AbbVie Inc., Novartis AG, Abbott Laboratories, Fresenius SE & Co. KGaA, GSK PLC, Takeda Pharmaceutical Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Menarini Group, Dr. Reddy's Laboratories Ltd., Cipla Limited, Aspen Pharmacare Holdings Limited, Lupin Limited, Zydus Lifesciences Limited, Eurofarma Laboratorios S.A., Glenmark Pharmaceuticals Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Alkem Laboratories Limited, Zhejiang Huahai Pharmaceutical Co. Ltd., Zhejiang Medicine Co. Ltd., Aurobindo Pharma Limited, Zhejiang Jingxin Pharmaceutical Co. Ltd., ACS Dobfar SpA, Melinta Therapeutics LLC, Shandong Luoxin Pharmaceutical Group Co. Ltd., Wakunaga Pharmaceutical Co. Ltd., Flynn Pharma Ltd.

Asia-Pacific was the largest region in the acute bacterial skin and skin structure infections market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the acute bacterial skin and skin structure infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the acute bacterial skin and skin structure infections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The acute bacterial skin and skin structure infections market consists of revenues earned by entities by providing services such as diagnostic testing, surgical procedures for abscess drainage or debridement, inpatient and outpatient healthcare services, and home healthcare and wound care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The acute bacterial skin and skin structure infections market also includes sales of wound dressings and bandages, medical devices for wound care, vaccines, hydrogen peroxide, and fusidic acid. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Bacterial Skin And Skin Structure Infections Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute bacterial skin and skin structure infections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute bacterial skin and skin structure infections? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acute bacterial skin and skin structure infections market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type Of Infection: Hospital-acquired Acute Bacterial Skin And Skin Structure Infections; Community-acquired Acute Bacterial Skin And Skin Structure Infections
  • 2) By Active Ingredients: Delafloxacin; Vancomycin; Ceftaroline fosamil; Oritavancin; Tedizolid; Daptomycin; Tigecycline; Linezolid; Other Active Ingredients
  • 3) By Route of Administration: Oral; Parenteral; Topical
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • 5) By Application: Cellulitis; Abscess; Surgical Wounds; Traumatic Wound
  • Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Novartis AG; Abbott Laboratories; Fresenius SE & Co. KGaA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acute Bacterial Skin And Skin Structure Infections Market Characteristics

3. Acute Bacterial Skin And Skin Structure Infections Market Trends And Strategies

4. Acute Bacterial Skin And Skin Structure Infections Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Acute Bacterial Skin And Skin Structure Infections Market Size and Growth

  • 5.1. Global Acute Bacterial Skin And Skin Structure Infections Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Acute Bacterial Skin And Skin Structure Infections Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Acute Bacterial Skin And Skin Structure Infections Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Acute Bacterial Skin And Skin Structure Infections Market Segmentation

  • 6.1. Global Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital-acquired Acute Bacterial Skin And Skin Structure Infections
  • Community-acquired Acute Bacterial Skin And Skin Structure Infections
  • 6.2. Global Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Delafloxacin
  • Vancomycin
  • Ceftaroline fosamil
  • Oritavancin
  • Tedizolid
  • Daptomycin
  • Tigecycline
  • Linezolid
  • Other Active Ingredients
  • 6.3. Global Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Topical
  • 6.4. Global Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 6.5. Global Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cellulitis
  • Abscess
  • Surgical Wounds
  • Traumatic Wound

7. Acute Bacterial Skin And Skin Structure Infections Market Regional And Country Analysis

  • 7.1. Global Acute Bacterial Skin And Skin Structure Infections Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Acute Bacterial Skin And Skin Structure Infections Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections Market

  • 8.1. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Acute Bacterial Skin And Skin Structure Infections Market

  • 9.1. China Acute Bacterial Skin And Skin Structure Infections Market Overview
  • 9.2. China Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Acute Bacterial Skin And Skin Structure Infections Market

  • 10.1. India Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Acute Bacterial Skin And Skin Structure Infections Market

  • 11.1. Japan Acute Bacterial Skin And Skin Structure Infections Market Overview
  • 11.2. Japan Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Acute Bacterial Skin And Skin Structure Infections Market

  • 12.1. Australia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Acute Bacterial Skin And Skin Structure Infections Market

  • 13.1. Indonesia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Acute Bacterial Skin And Skin Structure Infections Market

  • 14.1. South Korea Acute Bacterial Skin And Skin Structure Infections Market Overview
  • 14.2. South Korea Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Acute Bacterial Skin And Skin Structure Infections Market

  • 15.1. Western Europe Acute Bacterial Skin And Skin Structure Infections Market Overview
  • 15.2. Western Europe Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Acute Bacterial Skin And Skin Structure Infections Market

  • 16.1. UK Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Acute Bacterial Skin And Skin Structure Infections Market

  • 17.1. Germany Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Acute Bacterial Skin And Skin Structure Infections Market

  • 18.5. France Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Acute Bacterial Skin And Skin Structure Infections Market

  • 19.9. Italy Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Acute Bacterial Skin And Skin Structure Infections Market

  • 20.13. Spain Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Acute Bacterial Skin And Skin Structure Infections Market

  • 21.1. Eastern Europe Acute Bacterial Skin And Skin Structure Infections Market Overview
  • 21.2. Eastern Europe Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Acute Bacterial Skin And Skin Structure Infections Market

  • 22.1. Russia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Acute Bacterial Skin And Skin Structure Infections Market

  • 23.1. North America Acute Bacterial Skin And Skin Structure Infections Market Overview
  • 23.2. North America Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Acute Bacterial Skin And Skin Structure Infections Market

  • 24.1. USA Acute Bacterial Skin And Skin Structure Infections Market Overview
  • 24.2. USA Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Acute Bacterial Skin And Skin Structure Infections Market

  • 25.1. Canada Acute Bacterial Skin And Skin Structure Infections Market Overview
  • 25.2. Canada Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Acute Bacterial Skin And Skin Structure Infections Market

  • 26.1. South America Acute Bacterial Skin And Skin Structure Infections Market Overview
  • 26.2. South America Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Acute Bacterial Skin And Skin Structure Infections Market

  • 27.1. Brazil Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Acute Bacterial Skin And Skin Structure Infections Market

  • 28.1. Middle East Acute Bacterial Skin And Skin Structure Infections Market Overview
  • 28.2. Middle East Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Acute Bacterial Skin And Skin Structure Infections Market

  • 29.1. Africa Acute Bacterial Skin And Skin Structure Infections Market Overview
  • 29.2. Africa Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Type Of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Active Ingredients, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Acute Bacterial Skin And Skin Structure Infections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Acute Bacterial Skin And Skin Structure Infections Market Competitive Landscape And Company Profiles

  • 30.1. Acute Bacterial Skin And Skin Structure Infections Market Competitive Landscape
  • 30.2. Acute Bacterial Skin And Skin Structure Infections Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. AbbVie Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Novartis AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Fresenius SE & Co. KGaA
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Acute Bacterial Skin And Skin Structure Infections Market Other Major And Innovative Companies

  • 31.1. GSK PLC
  • 31.2. Takeda Pharmaceutical Company Limited
  • 31.3. Viatris Inc.
  • 31.4. Teva Pharmaceutical Industries Ltd.
  • 31.5. Sun Pharmaceutical Industries Limited
  • 31.6. Menarini Group
  • 31.7. Dr. Reddy's Laboratories Ltd.
  • 31.8. Cipla Limited
  • 31.9. Aspen Pharmacare Holdings Limited
  • 31.10. Lupin Limited
  • 31.11. Zydus Lifesciences Limited
  • 31.12. Eurofarma Laboratorios S.A.
  • 31.13. Glenmark Pharmaceuticals Ltd.
  • 31.14. Jiangsu Hansoh Pharmaceutical Group Co. Ltd.
  • 31.15. Alkem Laboratories Limited

32. Global Acute Bacterial Skin And Skin Structure Infections Market Competitive Benchmarking

33. Global Acute Bacterial Skin And Skin Structure Infections Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Acute Bacterial Skin And Skin Structure Infections Market

35. Acute Bacterial Skin And Skin Structure Infections Market Future Outlook and Potential Analysis

  • 35.1 Acute Bacterial Skin And Skin Structure Infections Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Acute Bacterial Skin And Skin Structure Infections Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Acute Bacterial Skin And Skin Structure Infections Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer